Unstable tachycardia: synchronized cardioversion or drugs?
Two patients can share the same heart rate and need opposite plans. Stability decides between a shock and a drug; QRS width and regularity then choose the drug.
Chapters (11)
Decide between synchronized cardioversion and drug therapy for a tachyarrhythmia with a pulse, based on stability and QRS width.
The short version
- Unstable with a pulse means synchronized cardioversion, except polymorphic ventricular tachycardia, which gets a defibrillation dose.
- If stable, the QRS width and regularity choose the drug.
- 2025 AHA starting doses: 100 J for narrow-complex tachycardia and monomorphic ventricular tachycardia, 200 J for atrial fibrillation or flutter; increase if the first shock fails.
- Never give diltiazem to a wide-complex rhythm.
- A sinus tachycardia from fever or bleeding needs its cause treated, not a shock.
Two patients, the same heart rate
Two patients are on the monitors, and both show a heart rate of 150. The first is chatting about last night's football match. The second is gray, sweaty and confused. Same rate, opposite plans.
A heart rate alone does not tell you what to do. What matters is whether the rhythm is the reason the patient is sick, and what the QRS looks like. The chatty patient has time. The gray patient does not, and the choice between a shock and a drug follows from that difference.
This lesson is about unstable tachycardia: how to decide between a shock and a drug for a fast rhythm with a pulse, using two things. Is the patient stable, and is the QRS narrow or wide?
QRS width tells you where the rhythm starts
The QRS is ventricular depolarization, and its width tells you where the rhythm starts. A narrow QRS, under about 0.12 seconds, usually means the impulse travels the normal conduction system, so the rhythm starts above the ventricles.[4]
A wider QRS usually means the ventricles, although a supraventricular rhythm with aberrant conduction can look the same.[4]
In practice this makes the QRS a quick clue at the bedside: narrow points to a supraventricular rhythm, wide to a ventricular one. Most regular wide-complex tachycardias are ventricular tachycardia, so when you are unsure, a wide, regular rhythm is treated as ventricular tachycardia.[3]
| QRS | Usual origin | Caveat |
|---|---|---|
| Narrow (under about 0.12 s) | Above the ventricles (supraventricular) | Normal conduction system used |
| Wide | Usually the ventricles | Supraventricular rhythm with aberrant conduction can look the same |
Step one: is the tachycardia causing instability?
Stability comes first. Treat the rhythm only if it is causing the problem: a sinus tachycardia from fever or bleeding needs its cause treated, not a shock.[3]
- Low blood pressure
- Altered mental status
- Signs of shock
- Ischemic chest discomfort
- Acute heart failure
The key phrase is that the rhythm must be the cause. A patient who is tachycardic because of fever or bleeding may look unwell, but shocking the rhythm does not fix the fever or the blood loss.[3]
If any are present and the rhythm is the cause, give synchronized cardioversion now.[3]
Synchronized cardioversion: what it means, sedation and energies
Synchronized means the machine times the shock to the R wave, to avoid the vulnerable period of the cardiac cycle, when a shock could trigger ventricular fibrillation.[5] If the patient is awake, consider sedation first.[3]
| Rhythm | Starting energy |
|---|---|
| Narrow-complex tachycardia | 100 J |
| Monomorphic ventricular tachycardia | 100 J |
| Atrial fibrillation or flutter | 200 J |
These are starting doses. If the first shock fails, increase the energy.[1] The doses differ between sources and years, so the practice question below does not ask for an energy; it tests the decision.
Stable tachycardia: QRS width and regularity choose the drug
In the stable patient, the QRS width and the regularity decide.[3]
| Rhythm | Approach |
|---|---|
| Narrow and regular | Vagal maneuvers, then adenosine 6 mg by fast push, and 12 mg if needed |
| Narrow and irregular (usually atrial fibrillation) | Rate control with a beta blocker or diltiazem, unless there is heart failure with a weak pump or a pre-excitation pathway |
| Wide and regular | Treat as ventricular tachycardia unless you know otherwise; get expert help; procainamide or amiodarone |
In the narrow regular case, vagal maneuvers come first and adenosine second. In the narrow irregular case the rhythm is usually atrial fibrillation, and the goal is rate control; heart failure with a weak pump and a pre-excitation pathway are the two exceptions that change that plan.[3]
The 2025 algorithm dropped sotalol.[1] Never give diltiazem to a wide rhythm.
Worked example: back to the two patients
- Chatty patient: stable, so there is time for a 12-lead ECG
- Choose the drug by the QRS and regularity: if narrow and regular, vagal maneuvers then adenosine 6 mg (12 mg if needed)
- Gray, sweaty, confused patient: unstable, so synchronized cardioversion
- Start at the dose for the rhythm: 100 J for narrow-complex tachycardia or monomorphic ventricular tachycardia, 200 J for atrial fibrillation or flutter; polymorphic ventricular tachycardia gets a defibrillation dose
Practice question
Original · USMLE styleA 62-year-old man with coronary artery disease comes to the emergency department because of palpitations and light-headedness for 30 minutes. He is confused and diaphoretic. Pulse is 172/min and regular, respirations are 24/min, and blood pressure is 78/48 mm Hg. Oxygen saturation is 94% on room air. He has no known drug allergies. An ECG shows a regular wide-complex tachycardia with a QRS duration of 0.14 seconds and no visible P waves. An intravenous line is in place and the cardiac monitor and defibrillator are available.
Common questions
When is synchronized cardioversion used for tachycardia?
When the patient has a pulse and is unstable because of the rhythm. Signs of instability are low blood pressure, altered mental status, signs of shock, ischemic chest discomfort and acute heart failure.
What does synchronized mean in cardioversion?
The machine times the shock to the R wave, to avoid the vulnerable period of the cardiac cycle, when a shock could trigger ventricular fibrillation.
What are the 2025 AHA starting energies for cardioversion?
100 J for narrow-complex tachycardia and monomorphic ventricular tachycardia, and 200 J for atrial fibrillation or flutter. Increase the energy if the first shock fails.
How is polymorphic ventricular tachycardia treated?
Polymorphic ventricular tachycardia, such as torsades de pointes, gets a defibrillation dose, not a synchronized shock.
Which drug should never be given to a wide-complex tachycardia?
Diltiazem. A stable wide regular rhythm is treated as ventricular tachycardia, with expert help and procainamide or amiodarone.
Transcript
Read the full narration, by chapter641 words
0:00Two patients, the same heart rate
Two patients are on the monitors, and both show a heart rate of 150. The first is chatting about last night's football match. The second is gray, sweaty, and confused. Same rate, opposite plans. How do you choose?
0:15Today's goal: stable or unstable, narrow or wide
Today: decide between a shock and a drug for a fast rhythm, using two things: is the patient stable, and is the QRS narrow or wide?
0:25QRS width tells you where the rhythm starts
From the ECG basics lesson, the QRS is ventricular depolarization, and its width tells you where the rhythm starts. A narrow QRS, under about 0.12 seconds, means the impulse travels the normal conduction system, so the rhythm starts above the ventricles. A wider QRS usually means the ventricles, although a supraventricular rhythm with aberrant conduction can look the same.
0:53Step one: stability and the five signs of instability
Step one is always stability. Treat the rhythm only if it is causing the problem: a sinus tachycardia from fever or bleeding needs its cause treated, not a shock. The signs of instability are low blood pressure, altered mental status, signs of shock, ischemic chest discomfort, and acute heart failure. If any are present and the rhythm is the cause, give synchronized cardioversion now.
1:20What "synchronized" means, and sedation
Synchronized means the machine times the shock to the R wave, to avoid the vulnerable period of the cardiac cycle, when a shock could trigger ventricular fibrillation. If the patient is awake, consider sedation first. The 2025 American Heart Association
1:35The 2025 AHA starting energies
starting doses are: narrow-complex tachycardia, 100 joules; monomorphic ventricular tachycardia, 100 joules; atrial fibrillation or flutter, 200 joules. If the first shock fails, increase the energy. One exception: polymorphic ventricular tachycardia, such as torsades de pointes, gets a defibrillation dose, not synchronized.
2:03Stable patients: narrow regular, narrow irregular, wide regular
Now the stable patient, where the QRS width and the regularity decide. Narrow and regular: try vagal maneuvers, then adenosine, 6 mg by fast push, and 12 mg if needed. Narrow and irregular is usually atrial fibrillation: control the rate with a beta blocker or diltiazem, unless there is heart failure with a weak pump or a pre-excitation pathway. Wide and regular: treat it as ventricular tachycardia unless you know otherwise. Get expert help, and use procainamide or amiodarone. Never give diltiazem to a wide rhythm. The 2025 algorithm dropped sotalol.
2:46Back to the two patients
Back to our two patients. The chatty one is stable, so he gets time: a 12-lead ECG, and a drug chosen by the QRS. The gray one is unstable, so he gets a synchronized shock at the starting dose for his rhythm.
3:02Your turn: practice question
Your turn. A 62-year-old man with coronary artery disease has had palpitations and light-headedness for 30 minutes. He is confused and sweaty. His pulse is 172 a minute and regular, his breathing 24 a minute, his blood pressure is 78 over 48, and his oxygen saturation is 94%. The ECG shows a regular wide-complex tachycardia, with a QRS of about 0.14 seconds and no visible P waves. Which of the following is the most appropriate next step in management? A, intravenous adenosine. B, intravenous amiodarone. C, intravenous procainamide. D, synchronized cardioversion. E, unsynchronized defibrillation.
3:55Pause, then why A, B, C and E are out
Pause here and decide. A is out: adenosine is for a stable regular tachycardia, and it should not be given to an unstable patient like him. B is out: amiodarone is a drug for the stable patient with a wide rhythm. C is out: the same goes for procainamide. E is out: unsynchronized shocks are for polymorphic or pulseless rhythms, and he has a pulse and a regular rhythm.
4:25The answer, high-yield recap and next lesson
So the answer is D. He is unstable, so he needs synchronized cardioversion now, whatever the QRS width. Three things to keep. One: unstable with a pulse means synchronized cardioversion, with the exception of polymorphic ventricular tachycardia, which is defibrillated. Two: if stable, the QRS width and regularity choose the drug. Three: starting doses are 100 joules for narrow-complex tachycardia and monomorphic ventricular tachycardia, and 200 for atrial fibrillation or flutter. Next, bradycardia: unstable versus stable.
Sources
Numbers in the text, e.g. [1], point here- American Heart Association. 2025 Interim Training Materials: ACLS Provider Manual and ACLS for Experienced Providers Manual and Resource Text Changes. irishheart.ie/wp-content/uploads/2025/11/2025_IntrmTrngMtrls_PM_ACLS-EP_Intl.pdf
- The Hospitalist. What's new, what matters: implementing the 2025 ACLS guidelines. the-hospitalist.org/hospitalist/article/41486/cardiology/whats-new-what-matters-implementing-the-2025-acls-guidelines/
- Singapore Advanced Cardiac Life Support Guidelines 2026. Singapore Med J. europepmc.org/article/PMC/PMC13515999
- Narrow Complex Tachycardia Is Not Always a Supraventricular Tachycardia. Cureus 2025. europepmc.org/article/PMC/PMC12665377
- Wikipedia: Synchronized electrical cardioversion; Tachycardia; QRS complex (secondary). en.wikipedia.org/wiki/Synchronized_electrical_cardioversion
Guideline basis: the 2025 American Heart Association adult tachycardia with a pulse algorithm and standard references, reviewed 13 Nov 2026. The 2025 starting energies are taken from AHA's 2025 interim training materials change list; doses differ between sources and years, so the question does not ask for an energy.
The practice question is original and its patient is synthetic. Every fact is checked against the sources above in independent accuracy reviews. Always follow your local guidelines and your own laboratory’s ranges.
Image credits. Illustrations: Servier Medical Art (smart.servier.com), CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), adapted (recoloured, resized): "Heart conduction", "Systolic heart failure" (used as a plain heart), "Smart defibrillator", "Smart syringe", "ECG recorder". Icons: Health Icons (healthicons.org), CC0: head, thermometer, blood bag. Original diagrams: all schematic ECG strips, the magnified QRS card, the energy table, the instability checklist and the decision tree. No AI-generated teaching images.
Corrections. None so far. Spotted an error? Email info@medservatory.com with the lesson code MS-CK-EMER-010.
For exam study only, not medical advice. Read the medical disclaimer.
In this series
Playlist on YouTube- EP 01Types of shock: telling the four patterns apart at the bedside5:07
- EP 02Sepsis and septic shock: the first hour in order5:11
- EP 03Tension pneumothorax vs cardiac tamponade: obstructive shock5:11
- EP 04Trauma primary survey: the xABCDE order5:11
- EP 05Acute shortness of breath: the differential and first tests5:08
- EP 06Anaphylaxis treatment: recognition and epinephrine first5:29
- EP 07Unstable tachycardia: synchronized cardioversion or drugs?5:08
- EP 08Bradycardia management: atropine, pacing and AV block types5:04
- EP 09Altered mental status workup: the initial six steps5:26
- EP 10Acetaminophen overdose: the nomogram, NAPQI and NAC4:57